- Previous Close
51.00 - Open
51.00 - Bid 45.57 x 27000
- Ask 50.57 x 21500
- Day's Range
51.00 - 51.00 - 52 Week Range
45.05 - 51.00 - Volume
252 - Avg. Volume
5 - Market Cap (intraday)
942.869M - Beta (5Y Monthly) -0.34
- PE Ratio (TTM)
7.27 - EPS (TTM)
6.20 - Earnings Date Mar 5, 2025 - Mar 10, 2025
- Forward Dividend & Yield 1.87 (4.16%)
- Ex-Dividend Date May 9, 2024
- 1y Target Est
--
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
www.draeger.comRecent News: DGWPF
View MorePerformance Overview: DGWPF
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DGWPF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DGWPF
View MoreValuation Measures
Market Cap
943.48M
Enterprise Value
1.03B
Trailing P/E
7.26
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.24
Price/Book (mrq)
0.57
Enterprise Value/Revenue
0.30
Enterprise Value/EBITDA
5.72
Financial Highlights
Profitability and Income Statement
Profit Margin
3.39%
Return on Assets (ttm)
3.53%
Return on Equity (ttm)
8.10%
Revenue (ttm)
3.35B
Net Income Avi to Common (ttm)
113.44M
Diluted EPS (ttm)
6.20
Balance Sheet and Cash Flow
Total Cash (mrq)
179.8M
Total Debt/Equity (mrq)
26.46%
Levered Free Cash Flow (ttm)
205.79M